This potential tau-atherosclerosis interaction aligns with established mechanisms whereby CNS-derived tau proteins may amplify peripheral inflammation through microglial activation and blood-brain barrier dysfunction (Hossen et al., 2024; Kim et al., 2024), though causal relationships require further longitudinal validation. The gene discussed is MAPT; the disease is atherosclerosis.